Skip to main content
. 2011 Dec 7;103(24):1851–1858. doi: 10.1093/jnci/djr485

Table 1.

The clinical and sociodemographic variables for the included patients and trials for the symptoms pain, fatigue, vomiting, nausea, diarrhea, and constipation*

Clinical and sociodemographic variables Pain, No. (%) (nine RCTs; n = 1467) Fatigue, No. (%) (five RCTs; n = 1237) Vomiting, No. (%) (five RCTs; n = 824) Nausea, No. (%) (six RCTs; n = 813) Diarrhea, No. (%) (six RCTs; n = 815) Constipation, No. (%) (four RCTs; n = 751)
Age, y
    ≤60 585 (39.9) 827 (66.9) 491 (59.6) 481 (59.2) 487 (59.8) 476 (63.4)
    >60 882 (60.1) 410 (33.1) 333 (40.4) 332 (40.8) 328 (40.2) 275 (36.6)
Performance status
    WHO 0-1 1,213 (82.7) 1,118 (90.4) 753 (91.4) 742 (91.3) 745 (91.4) 696 (92.7)
    WHO 2-3 254 (17.3) 118 (9.5) 71 (8.6) 71 (8.7) 70 (8.6) 55 (7.3)
Sex
    Male 1,018 (69.4) 731 (59.1) 501 (60.8) 501 (61.6) 497 (61) 430 (57.3)
    Female 449 (30.6) 506 (40.9) 323 (39.2) 312 (38.4) 318 (39) 321 (42.7)
Metastasis
    No 183 (12.5) 107 (8.6) 108 (13.1) 107 (13.2) 108 (13.3) 108 (14.4)
    Yes 1,214 (82.8) 633 (51.2%) 715 (86.8%) 705 (86.7%) 706 (86.6%) 642 (85.5%)
Cancer site
    Brain 0 496 (40) 0 0 0 0
    Colon or rectum 371 (25.3) 370 (29.9) 378 (45.9) 377 (46.4) 375 (46) 376 (50)
    Lung 343 (23.4) 0 0 0 0 0
    Ovary 69 (4.7) 0 0 0 0 0
    Prostate 542 (36.9) 0 69 (8.4) 69 (8.5) 68 (8.3) 0
    Breast 82 (5.6) 8 (0.7) 8 (0.9) 0 8 (1) 8 (1.1)
    Melanoma 60 (4.1) 304 (24.6) 308 (37.4) 306 (37.6) 303 (37.2) 306 (40.8)
    Pancreas 0 59 (4.8) 61 (7.4) 61 (7.5) 61 (7.5) 61 (8.1)
*

Individual patient data for the variable “performance status” were unavailable for the symptom fatigue (n = 1), and data for the variable “metastasis” were unavailable for the symptoms pain (n = 70), fatigue (n = 497), vomiting (n = 1), nausea (n = 1), diarrhea (n = 1), and constipation (n = 1). For this reason, percentages do not always add up to 100%. RCT = randomized controlled trial; WHO = World Health Organization.